MarketCap
Facebook
X
Telegram
Orthofix Medical Balance Sheet 2025-2008 | OFIX
Brief overview of Orthofix Medical 's financial position
This overview follows the five latest available annual observations between 2021 and 2025.
Assets advanced +78.5% to $850.6 million from $476.6 million; annual growth near 15.6% reflects a fast increase in scale.
Liabilities grew faster than assets: +186.8% versus +78.5%. A substantial part of expansion was externally funded.
Internal capital represents 52.9% of the balance sheet, previously 70.7%. This is a strong capital position.
Each unit of equity supports about 0.17x of net debt. Dependence on debt remains comfortable.
The cash reserve occupies 9.6% of the balance sheet, previously 18.4%. It is one marker of short-term resilience.
Retained earnings are negative at -$368.3 million. This reduces the formal capital cushion, although large shareholder returns may have contributed.
What the balance sheet shows
Orthofix Medical 's balance sheet sends more positive than negative signals, but liabilities should not begin outpacing the capital base.
Annual Balance Sheet Orthofix Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
78.5 M | 77.8 M | 63.5 M | -29.8 M | -66.1 M | - | -46.9 M | -69.6 M | -81.2 M | -39.6 M | -63.7 M | -36.8 M | -10.5 M | -11 M | 177 M | - | - | - |
Long Term Debt |
157 M | 157 M | 93.1 M | 19.2 M | 19.9 M | - | - | - | - | - | - | - | 20 M | 20 M | 191 M | - | - | - |
Long Term Debt Current |
3.15 M | 4.02 M | 3.48 M | 1.64 M | 1.83 M | 2.09 M | 1.88 M | - | - | - | - | - | - | - | 17.5 M | 7.5 M | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | 83.1 M | 45.3 M | 29.3 M | 25.2 M | 27.9 M | 27.1 M | 45.9 M | 36.4 M | 205 M | - | - | - |
Total Current Liabilities |
170 M | 169 M | 165 M | 83.6 M | 106 M | 104 M | 84.9 M | 85.9 M | 79.4 M | 83.4 M | 82 M | 66.4 M | 70.4 M | 62.2 M | 186 M | 83.5 M | - | - |
Total Liabilities |
401 M | 390 M | 327 M | 122 M | 140 M | 169 M | 168 M | 131 M | 109 M | 109 M | 110 M | 93.6 M | 113 M | 105 M | 380 M | 303 M | - | - |
Retained Earnings |
-368 M | -276 M | -150 M | 1.25 M | 21 M | 59.4 M | 57.7 M | 87.1 M | 70.4 M | 64.2 M | 62.6 M | 65.4 M | 89.3 M | 149 M | 97.3 M | 98.3 M | - | - |
Total Assets |
851 M | 893 M | 925 M | 459 M | 477 M | 526 M | 496 M | 467 M | 405 M | 372 M | 400 M | 393 M | 423 M | 504 M | 696 M | 604 M | - | - |
Cash and Cash Equivalents |
82 M | 83.2 M | 33.1 M | 50.7 M | 87.8 M | 96.3 M | 69.7 M | 69.6 M | 81.2 M | 39.6 M | 63.7 M | 36.8 M | 28.9 M | 30.8 M | 32.7 M | 13.6 M | 13.3 M | 14.6 M |
Book Value |
450 M | 503 M | 599 M | 337 M | 337 M | 357 M | 328 M | 335 M | 297 M | 263 M | 290 M | 300 M | 310 M | 399 M | 315 M | 301 M | - | - |
Total Shareholders Equity |
450 M | 503 M | 599 M | 337 M | 337 M | 357 M | 328 M | 335 M | 297 M | 263 M | 290 M | 300 M | 296 M | 356 M | 292 M | 301 M | 240 M | 202 M |
All numbers in USD currency
Quarterly Balance Sheet Orthofix Medical
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
222 M | 221 M | 157 M | 157 M | 157 M | 157 M | 157 M | 112 M | 113 M | 115 M | 93.1 M | 70 M | 51 M | 45 M | 19.2 M | 19.4 M | - | 19.7 M | 19.9 M | 20 M | 20.2 M | 20.3 M | 22.3 M | 22.3 M | 100 M | 22.3 M | 20.6 M | 20.6 M | 20.6 M | 20.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
444 M | 451 M | 401 M | 390 M | 379 M | 365 M | 390 M | 342 M | 336 M | 336 M | 327 M | 290 M | 261 M | 253 M | 122 M | 116 M | - | 126 M | 140 M | 136 M | 140 M | 159 M | 169 M | 169 M | 169 M | 169 M | 168 M | 168 M | 168 M | 168 M | 131 M | 131 M | 131 M | 131 M | 109 M | 109 M | 109 M | 109 M | 109 M | 109 M | 109 M | 109 M | 110 M | 110 M | 110 M | 110 M | 93.3 M | 93.6 M | 93.6 M | 93.6 M | 116 M | 116 M | 116 M | 116 M | 108 M | 105 M | 105 M | 105 M | 393 M | 389 M | 389 M | 380 M |
Retained Earnings |
-405 M | -389 M | -368 M | -366 M | -343 M | -329 M | -276 M | -247 M | -220 M | -186 M | -150 M | -128 M | -99.1 M | -59.7 M | 1.25 M | 8.31 M | - | 16.5 M | 21 M | 53.8 M | 56 M | 53.6 M | 59.4 M | 59.4 M | 59.4 M | 59.4 M | 57.7 M | 57.7 M | 57.7 M | 57.7 M | 87.1 M | 87.1 M | 87.1 M | 87.1 M | 70.4 M | 70.4 M | 70.4 M | 70.4 M | 64.2 M | 64.2 M | 64.2 M | 64.2 M | 62.6 M | 62.6 M | 62.6 M | 62.6 M | 65.4 M | 65.4 M | 65.4 M | 65.4 M | 73.9 M | 73.9 M | 73.9 M | 73.9 M | 103 M | 115 M | 115 M | 115 M | 72 M | 97.3 M | 97.3 M | 97.3 M |
Total Assets |
873 M | 887 M | 851 M | 833 M | 837 M | 823 M | 893 M | 868 M | 882 M | 906 M | 925 M | 906 M | 901 M | 917 M | 459 M | 450 M | - | 462 M | 477 M | 500 M | 502 M | 514 M | 526 M | 526 M | 526 M | 526 M | 496 M | 496 M | 496 M | 496 M | 467 M | 467 M | 467 M | 467 M | 405 M | 405 M | 405 M | 405 M | 372 M | 372 M | 372 M | 372 M | 400 M | 400 M | 400 M | 400 M | 393 M | 393 M | 393 M | 393 M | 412 M | 412 M | 412 M | 412 M | 465 M | 473 M | 473 M | 473 M | 685 M | 704 M | 704 M | 696 M |
Cash and Cash Equivalents |
104 M | 120 M | 82 M | 62.9 M | 65.6 M | 58 M | 83.2 M | 30.1 M | 26.4 M | 27 M | 33.1 M | 33.7 M | 37.6 M | 50 M | 50.7 M | 51.7 M | - | 71.9 M | 87.8 M | 82.7 M | 80 M | 94.6 M | 96.3 M | 96.3 M | 96.3 M | 96.3 M | 69.7 M | 69.7 M | 69.7 M | 69.7 M | 69.6 M | 69.6 M | 69.6 M | 69.6 M | 81.2 M | 81.2 M | 81.2 M | 81.2 M | 39.6 M | 39.6 M | 39.6 M | 39.6 M | 63.7 M | 63.7 M | 63.7 M | 63.7 M | 36.8 M | 36.8 M | 36.8 M | 36.8 M | 28.9 M | 28.9 M | 28.9 M | 28.9 M | 30.8 M | 31.1 M | 31.1 M | 31.1 M | 32.7 M | 33.2 M | 33.2 M | 33.2 M |
Book Value |
429 M | 435 M | 450 M | 442 M | 458 M | 458 M | 503 M | 526 M | 546 M | 570 M | 599 M | 615 M | 640 M | 664 M | 337 M | 334 M | - | 336 M | 337 M | 365 M | 362 M | 355 M | 357 M | 357 M | 357 M | 357 M | 328 M | 328 M | 328 M | 328 M | 335 M | 335 M | 335 M | 335 M | 297 M | 297 M | 297 M | 297 M | 263 M | 263 M | 263 M | 263 M | 290 M | 290 M | 290 M | 290 M | 300 M | 300 M | 300 M | 300 M | 296 M | 296 M | 296 M | 296 M | 356 M | 368 M | 368 M | 368 M | 292 M | 315 M | 315 M | 315 M |
Total Shareholders Equity |
429 M | 435 M | 450 M | 442 M | 458 M | 458 M | 503 M | 526 M | 546 M | 570 M | 599 M | 615 M | 640 M | 664 M | 337 M | 334 M | 342 M | 336 M | 337 M | 365 M | 362 M | 355 M | 357 M | 357 M | 357 M | 357 M | 328 M | 328 M | 328 M | 328 M | 335 M | 335 M | 335 M | 335 M | 297 M | 297 M | 297 M | 297 M | 263 M | 263 M | 263 M | 263 M | 290 M | 290 M | 290 M | 290 M | 300 M | 300 M | 300 M | 300 M | 296 M | 296 M | 296 M | 296 M | 356 M | 368 M | 368 M | 368 M | 280 M | 315 M | 315 M | 315 M |
All numbers in USD currency
Balance Sheet is a fundamental financial report of Orthofix Medical , providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
USA
France
China
Israel
Britain
Canada
